Skip to main content

Orbimed Advisors LLC

13F filer · CIK 0001055951
Reported Aug 14, 2026
13F portfolio value$5.4BU.S. long equity reported on 13F
Positions116Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight42.1%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 2026116 positions
EWTXEdgewise Therapeutics, Inc.$631M11.68%14.40%Not reportedQ1 2021
ELVNEnliven Therapeutics, Inc.$344M6.37%9.25%Not reportedQ1 2023
LLYELI LILLY & Co$309M5.73%0.03%Not reportedQ1 2014
MBXMBX Biosciences, Inc.$189M3.51%7.15%Not reportedQ3 2024
SVASinovac Biotech Ltd$184M3.42%3.78%Not reportedQ2 2013
AZNAstrazeneca PLC$171M3.17%Not reportedNot reportedQ4 2019
GPCRStructure Therapeutics Inc.$119M2.20%1.03%Not reportedQ2 2024
SIONSionna Therapeutics, Inc.$112M2.08%5.66%Not reportedQ1 2025
CRVSCorvus Pharmaceuticals, Inc.$107M1.98%8.52%Not reportedQ1 2016
AVBPArriVent BioPharma, Inc.$105M1.95%6.27%Not reportedQ1 2024
GHGuardant Health, Inc.$87.6M1.62%0.44%Not reportedQ4 2018
ARGXArgenx SE$86.2M1.60%0.15%Not reportedQ3 2017
MRKMerck & Co., Inc.$85.2M1.58%0.03%Not reportedQ2 2013
QUREuniQure N.V.$83.3M1.54%2.61%Not reportedQ1 2016
PRAXPraxis Precision Medicines, Inc.$77M1.43%0.82%Not reportedQ4 2020
EWEdwards Lifesciences Corp$75.5M1.40%0.14%Not reportedQ2 2013
PRLDPrelude Therapeutics Inc$73.2M1.36%17.23%Not reportedQ3 2020
ABVXAbivax S.A.$72.8M1.35%0.70%Not reportedQ3 2025
DYNDyne Therapeutics, Inc.$71.9M1.33%1.95%Not reportedQ3 2020
NTRANatera, Inc.$71.1M1.32%0.18%Not reportedQ3 2015
CGONCG Oncology, Inc.$69.1M1.28%1.10%Not reportedQ3 2024
UNHUnitedhealth Group Inc$67M1.24%0.02%Not reportedQ2 2013
SPRYARS Pharmaceuticals, Inc.$66.4M1.23%8.34%Not reportedQ4 2020
ASNDAscendis Pharma A/S$65.2M1.21%0.39%Not reportedQ1 2015
HUMHumana Inc$65.2M1.21%0.14%Not reportedQ1 2016
COGTCogent Biosciences, Inc.$65.1M1.21%0.98%Not reportedQ4 2020
BSXBoston Scientific Corp$63.3M1.17%0.10%Not reportedQ3 2013
ISRGIntuitive Surgical Inc$62.8M1.16%0.04%Not reportedQ4 2013
MLYSMineralys Therapeutics, Inc.$56.9M1.05%2.39%Not reportedQ1 2024
ODTXOdyssey Therapeutics, Inc.$56.2M1.04%6.27%NewQ2 2026
XENEXenon Pharmaceuticals Inc.$53.9M1.00%0.92%Not reportedQ3 2016
ARQTArcutis Biotherapeutics, Inc.$53.5M0.99%1.63%Not reportedQ1 2020
BMYBristol Myers Squibb Co$53.3M0.99%0.05%Not reportedQ2 2013
QTTBQ32 Bio Inc.$52.6M0.97%17.39%Not reportedQ1 2024
SYKStryker Corp$50.1M0.93%0.04%Not reportedQ2 2013
CAICaris Life Sciences, Inc.$50M0.93%0.99%Not reportedQ2 2025
TMOThermo Fisher Scientific Inc.$45.5M0.84%0.02%Not reportedQ2 2013
PVLAPalvella Therapeutics, Inc.$44.7M0.83%2.03%NewQ2 2026
ELVElevance Health, Inc.$44.4M0.82%0.05%Not reportedQ4 2014
STTKShattuck Labs, Inc.$43.8M0.81%6.26%Not reportedQ3 2025
UPBUpstream Bio, Inc.$39.4M0.73%10.40%Not reportedQ4 2024
CRNXCrinetics Pharmaceuticals, Inc.$37.4M0.69%0.94%Not reportedQ3 2018
RYTMRhythm Pharmaceuticals, Inc.$35.9M0.66%0.47%Not reportedQ4 2017
SNDXSyndax Pharmaceuticals Inc$33.7M0.62%1.73%Not reportedQ1 2016
FBRXForte Biosciences, Inc.$33.5M0.62%7.70%Not reportedQ2 2020
CMPXCompass Therapeutics, Inc.$33.3M0.62%8.45%Not reportedQ4 2021
NKTRNektar Therapeutics$32.5M0.60%2.28%Not reportedQ1 2023
KRYSKrystal Biotech, Inc.$30.9M0.57%0.28%Not reportedQ1 2019
AXSMAxsome Therapeutics, Inc.$28.8M0.53%0.22%Not reportedQ1 2025
KNSAKiniksa Pharmaceuticals International, plc$26.9M0.50%Not reportedNot reportedQ4 2025
Q4 2025Reported Feb 17, 2026103 positions
EWTXEdgewise Therapeutics, Inc.$385M7.86%14.61%Not reportedQ1 2021
LLYELI LILLY & Co$324M6.61%0.03%Not reportedQ1 2014
BSXBoston Scientific Corp$231M4.71%0.16%-0.4%Q3 2013
SVASinovac Biotech Ltd$184M3.77%3.78%Not reportedQ2 2013
EWEdwards Lifesciences Corp$157M3.21%0.32%+9.4%Q2 2013
UPBUpstream Bio, Inc.$155M3.16%10.50%Not reportedQ4 2024
ISRGIntuitive Surgical Inc$149M3.04%0.07%-8.3%Q4 2013
SIONSionna Therapeutics, Inc.$147M2.99%7.96%-3.9%Q1 2025
MBXMBX Biosciences, Inc.$124M2.53%8.76%-1.7%Q3 2024
ARGXArgenx SE$123M2.51%0.24%-15.3%Q3 2017
ELVNEnliven Therapeutics, Inc.$123M2.50%13.39%Not reportedQ1 2023
ALNYAlnylam Pharmaceuticals, Inc.$115M2.34%0.22%-4.2%Q1 2017
SYKStryker Corp$114M2.33%0.09%-9.5%Q2 2013
SPRYARS Pharmaceuticals, Inc.$96.6M1.97%8.35%Not reportedQ4 2020
TERNTerns Pharmaceuticals, Inc.$87M1.78%1.92%-71.5%Q1 2021
IRONDisc Medicine, Inc.$84.8M1.73%2.82%-24.6%Q4 2022
CAICaris Life Sciences, Inc.$84.1M1.72%1.10%+2.7%Q2 2025
NTRANatera, Inc.$83.8M1.71%0.26%-14.8%Q3 2015
CMPXCompass Therapeutics, Inc.$81.7M1.67%8.54%Not reportedQ4 2021
GPCRStructure Therapeutics Inc.$80.8M1.65%0.55%+2.0%Q2 2024
DHRDanaher Corp$68.6M1.40%0.04%+14.0%Q4 2019
CGONCG Oncology, Inc.$63M1.29%1.88%-12.2%Q3 2024
APLSApellis Pharmaceuticals, Inc.$61M1.25%1.92%+4.6%Q4 2018
AVBPArriVent BioPharma, Inc.$60.9M1.24%7.13%Not reportedQ1 2024
CICigna Group$56.4M1.15%0.08%+25.9%Q2 2013
RAPTRAPT Therapeutics, Inc.$55.6M1.14%5.93%+51.2%Q4 2021
CRVSCorvus Pharmaceuticals, Inc.$55.2M1.13%9.59%Not reportedQ1 2016
UTHRUNITED THERAPEUTICS Corp$51.3M1.05%0.24%-8.4%Q4 2013
ABVXAbivax S.A.$49.6M1.01%0.47%-3.2%Q3 2025
ROIVRoivant Sciences Ltd.$47.5M0.97%0.31%-19.3%Q2 2025
CRNXCrinetics Pharmaceuticals, Inc.$46.5M0.95%1.05%-9.1%Q3 2018
AXSMAxsome Therapeutics, Inc.$46.2M0.94%0.50%-52.4%Q1 2025
EYPTEyePoint, Inc.$45.1M0.92%2.98%+37.4%Q3 2022
RNAMAvidity Biosciences, Inc.$44.7M0.91%0.41%-62.2%Q2 2020
NBIXNeurocrine Biosciences Inc$44.6M0.91%0.31%-11.1%Q2 2013
DYNDyne Therapeutics, Inc.$43.1M0.88%1.34%-4.8%Q3 2020
BMYBristol Myers Squibb Co$41.8M0.85%0.04%Not reportedQ2 2013
PFEPfizer Inc$41.2M0.84%0.03%Not reportedQ2 2013
TRVITrevi Therapeutics, Inc.$39.9M0.82%2.49%-3.6%Q1 2025
NPCENeuroPace Inc$37.2M0.76%7.17%-8.0%Q2 2021
ASNDAscendis Pharma A/S$36.7M0.75%0.28%-10.4%Q1 2015
EXKEndeavour Silver Corp$35.7M0.73%0.13%-64.6%Q2 2013
MLYSMineralys Therapeutics, Inc.$35.6M0.73%1.20%-33.3%Q1 2024
ELVElevance Health, Inc.$34.7M0.71%0.04%Not reportedQ4 2014
FBRXForte Biosciences, Inc.$32.6M0.67%9.24%Not reportedQ2 2020
PRLDPrelude Therapeutics Inc$31.6M0.65%17.35%Not reportedQ3 2020
HELPCybin Inc.$31.4M0.64%17.78%NewQ4 2025
ORICOric Pharmaceuticals, Inc.$29.8M0.61%3.70%Not reportedQ2 2020
KRYSKrystal Biotech, Inc.$29.5M0.60%0.41%+16.6%Q1 2019
PRAXPraxis Precision Medicines, Inc.$27.9M0.57%0.38%Not reportedQ4 2020
Q3 2025Reported Nov 14, 202596 positions
EWTXEdgewise Therapeutics, Inc.$252M5.92%14.67%Not reportedQ1 2021
BSXBoston Scientific Corp$237M5.57%0.16%-13.7%Q3 2013
LLYELI LILLY & Co$230M5.40%0.03%-10.8%Q1 2014
SVASinovac Biotech Ltd$184M4.33%3.78%Not reportedQ2 2013
ELVNEnliven Therapeutics, Inc.$163M3.83%13.43%Not reportedQ1 2023
ALNYAlnylam Pharmaceuticals, Inc.$138M3.23%0.23%-11.8%Q1 2017
SYKStryker Corp$133M3.12%0.09%Not reportedQ2 2013
EWEdwards Lifesciences Corp$131M3.08%0.29%-1.4%Q2 2013
ISRGIntuitive Surgical Inc$128M3.02%0.08%-1.3%Q4 2013
ARGXArgenx SE$127M2.99%0.28%-17.2%Q3 2017
SIONSionna Therapeutics, Inc.$109M2.56%8.33%Not reportedQ1 2025
UPBUpstream Bio, Inc.$107M2.52%10.54%Not reportedQ4 2024
IRONDisc Medicine, Inc.$93.5M2.20%4.04%Not reportedQ4 2022
CAICaris Life Sciences, Inc.$91.8M2.16%1.08%Not reportedQ2 2025
SPRYARS Pharmaceuticals, Inc.$83.3M1.96%8.39%Not reportedQ4 2020
RNAMAvidity Biosciences, Inc.$71.4M1.68%1.12%-9.6%Q2 2020
MBXMBX Biosciences, Inc.$70.1M1.65%8.95%Not reportedQ3 2024
CGONCG Oncology, Inc.$69.6M1.63%2.21%-8.0%Q3 2024
NTRANatera, Inc.$69.1M1.62%0.31%-27.7%Q3 2015
AXSMAxsome Therapeutics, Inc.$64.6M1.52%1.06%+24.3%Q1 2025
TERNTerns Pharmaceuticals, Inc.$56.8M1.33%8.64%Not reportedQ1 2021
AVBPArriVent BioPharma, Inc.$55.9M1.31%7.41%Not reportedQ1 2024
MLYSMineralys Therapeutics, Inc.$55.7M1.31%1.86%+93.3%Q1 2024
EXKEndeavour Silver Corp$54.4M1.28%0.38%+63.8%Q2 2013
CMPXCompass Therapeutics, Inc.$53.3M1.25%8.57%Not reportedQ4 2021
CRVSCorvus Pharmaceuticals, Inc.$52.8M1.24%9.59%Not reportedQ1 2016
APLSApellis Pharmaceuticals, Inc.$52.6M1.24%1.84%+56.7%Q4 2018
DHRDanaher Corp$52.2M1.23%0.04%Not reportedQ4 2019
NBIXNeurocrine Biosciences Inc$49.6M1.17%0.35%-19.4%Q2 2013
UTHRUNITED THERAPEUTICS Corp$48.2M1.13%0.27%Not reportedQ4 2013
CICigna Group$46.9M1.10%0.06%Not reportedQ2 2013
CRNXCrinetics Pharmaceuticals, Inc.$45.8M1.08%1.16%-4.4%Q3 2018
ORICOric Pharmaceuticals, Inc.$43.7M1.03%3.74%+305.0%Q2 2020
JANXJanux Therapeutics, Inc.$43.2M1.01%2.94%+45.9%Q2 2021
ROIVRoivant Sciences Ltd.$41.1M0.97%0.39%-2.3%Q2 2025
ASNDAscendis Pharma A/S$38.2M0.90%0.32%+457.9%Q1 2015
SIBNSI-BONE, Inc.$38M0.89%5.96%Not reportedQ4 2018
SCPHScpharmaceuticals Inc.$34.4M0.81%11.37%Not reportedQ4 2017
ABVXAbivax S.A.$32.3M0.76%0.60%NewQ3 2025
GPCRStructure Therapeutics Inc.$31.9M0.75%0.63%-5.0%Q2 2024
TRVITrevi Therapeutics, Inc.$30.3M0.71%2.58%Not reportedQ1 2025
ITGRInteger Holdings Corp$30M0.70%0.83%-33.1%Q2 2024
DYNDyne Therapeutics, Inc.$29.3M0.69%1.62%+124.4%Q3 2020
RAPTRAPT Therapeutics, Inc.$28M0.66%6.57%-33.8%Q4 2021
CTMXCytomX Therapeutics, Inc.$27M0.63%5.13%Not reportedQ2 2021
NPCENeuroPace Inc$27M0.63%7.85%Not reportedQ2 2021
QUREuniQure N.V.$26.8M0.63%0.74%Not reportedQ1 2016
EYPTEyePoint, Inc.$25.6M0.60%2.58%Not reportedQ3 2022
AKROAkero Therapeutics, Inc.$25M0.59%0.66%+149.0%Q2 2023
ADCTADC Therapeutics SA$23.6M0.56%5.25%Not reportedQ2 2024
Q2 2025Reported Aug 14, 202594 positions
SVASinovac Biotech Ltd$334M8.34%3.78%Not reportedQ2 2013
BSXBoston Scientific Corp$302M7.55%0.19%Not reportedQ3 2013
LLYELI LILLY & Co$263M6.57%0.04%Not reportedQ1 2014
EWTXEdgewise Therapeutics, Inc.$203M5.08%14.73%+3.3%Q1 2021
ELVNEnliven Therapeutics, Inc.$160M3.99%13.44%Not reportedQ1 2023
ISRGIntuitive Surgical Inc$158M3.95%0.08%Not reportedQ4 2013
SPRYARS Pharmaceuticals, Inc.$145M3.61%8.40%Not reportedQ4 2020
SYKStryker Corp$142M3.55%0.09%Not reportedQ2 2013
EWEdwards Lifesciences Corp$134M3.34%0.29%+11.5%Q2 2013
ARGXArgenx SE$115M2.86%0.34%+0.6%Q3 2017
ALNYAlnylam Pharmaceuticals, Inc.$111M2.78%0.26%-1.2%Q1 2017
UNHUnitedhealth Group Inc$105M2.62%0.04%+67.2%Q2 2013
NTRANatera, Inc.$100M2.50%0.43%+8.5%Q3 2015
VRTXVertex Pharmaceuticals Inc / Ma$93.6M2.34%0.08%+31.5%Q2 2013
THCTenet Healthcare Corp$81.8M2.04%0.50%Not reportedQ2 2016
CAICaris Life Sciences, Inc.$81.1M2.03%1.08%NewQ2 2025
IRONDisc Medicine, Inc.$74.9M1.87%4.08%Not reportedQ4 2022
AVBPArriVent BioPharma, Inc.$65.9M1.65%8.07%Not reportedQ1 2024
SIONSionna Therapeutics, Inc.$64.3M1.61%8.40%Not reportedQ1 2025
UPBUpstream Bio, Inc.$62.5M1.56%10.58%Not reportedQ4 2024
NBIXNeurocrine Biosciences Inc$55.1M1.38%0.44%-53.1%Q2 2013
ITGRInteger Holdings Corp$53.3M1.33%1.24%-34.6%Q2 2024
RNAMAvidity Biosciences, Inc.$51.5M1.29%1.50%Not reportedQ2 2020
CGONCG Oncology, Inc.$48.8M1.22%2.46%-24.0%Q3 2024
SIBNSI-BONE, Inc.$48.5M1.21%6.00%-25.1%Q4 2018
MBXMBX Biosciences, Inc.$45.7M1.14%11.92%Not reportedQ3 2024
AXSMAxsome Therapeutics, Inc.$44.7M1.12%0.86%+10.7%Q1 2025
CMPXCompass Therapeutics, Inc.$39.6M0.99%11.01%-31.9%Q4 2021
CYTKCytokinetics Inc$35.6M0.89%0.90%-28.6%Q1 2024
CRNXCrinetics Pharmaceuticals, Inc.$33M0.83%1.22%+15.0%Q3 2018
EXKEndeavour Silver Corp$32.3M0.81%0.23%-10.7%Q2 2013
ROIVRoivant Sciences Ltd.$31.3M0.78%0.41%NewQ2 2025
XENEXenon Pharmaceuticals Inc.$29.7M0.74%1.23%Not reportedQ3 2016
NPCENeuroPace Inc$29.1M0.73%7.91%-23.3%Q2 2021
CRVSCorvus Pharmaceuticals, Inc.$28.7M0.72%9.62%+3.2%Q1 2016
TERNTerns Pharmaceuticals, Inc.$28.2M0.70%8.65%Not reportedQ1 2021
JANXJanux Therapeutics, Inc.$28M0.70%2.04%+59.6%Q2 2021
APLSApellis Pharmaceuticals, Inc.$25.7M0.64%1.17%+3.5%Q4 2018
GPCRStructure Therapeutics Inc.$24.9M0.62%0.69%+83.9%Q2 2024
SCPHScpharmaceuticals Inc.$23.1M0.58%11.37%Not reportedQ4 2017
CTMXCytomX Therapeutics, Inc.$19.2M0.48%10.50%Not reportedQ2 2021
TMOThermo Fisher Scientific Inc.$18.9M0.47%0.01%-64.0%Q2 2013
AGIOAgios Pharmaceuticals, Inc.$18.6M0.46%0.96%+71.4%Q1 2020
TRVITrevi Therapeutics, Inc.$18.1M0.45%2.72%+195.4%Q1 2025
ADCTADC Therapeutics SA$15.8M0.40%5.25%-1.0%Q2 2024
RYTMRhythm Pharmaceuticals, Inc.$15.7M0.39%0.39%-34.6%Q4 2017
FBRXForte Biosciences, Inc.$15.5M0.39%9.75%+101.8%Q2 2020
CGEMCullinan Therapeutics, Inc.$14.5M0.36%3.26%Not reportedQ1 2021
KROSKeros Therapeutics, Inc.$13.6M0.34%2.51%Not reportedQ2 2020
RAPTRAPT Therapeutics, Inc.$13.1M0.33%1.24%-87.5%Q4 2021
Premium opens every quarter this fund has filed

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.